Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2025-12-24 @ 11:32 PM
NCT ID:
NCT01937156
Eligibility Criteria:
Inclusion Criteria:
* Male or female aged ≥ 18years
* Histologically and/or cytologically confirmed cancer
* The physical status score ECOG ≤ 2
* Life expectancy of ≥3 months
* Will receive multi-day ME/HE chemotherapy (≥2 days) with the emetogenic potential of level 3-5
* In accordance with the indication of chemotherapy and basic requirements;
* Peripheral Haematology: Hb ≥ 9.0 g/dL, absolute neutrophil count ≥ 1.5×10e9/L, platelet count ≥ 80×10e9/L
* Blood biochemistry: Total bilirubin \< 1.25×ULN, ALT and AST ≤ 2.5×ULN; if liver metastasis, ALT and AST \< 5×ULN, Creatinine ≤ 1×ULN, basic normal serum electrolyte (Na, Ka, Cl, Ca)
* Other important organs function normally
* Subjects voluntarily participate and signed the informed consent form
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01937156
Study Brief:
Protocol Section:
NCT01937156